Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Journal of Biological Standardization
- Vol. 17 (4) , 331-342
- https://doi.org/10.1016/s0092-1157(89)80004-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- FlaviviridaeIntervirology, 1985
- A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodiesVirology, 1983
- Homogeneity of the Structural Glycoprotein from European Isolates of Tick-borne Encephalitis Virus: Comparison with Other FlavivirusesJournal of General Virology, 1981
- Formation of Polymeric Glycoprotein Complexes from a Flavivirus: Tick-borne Encephalitis VirusJournal of General Virology, 1980
- Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugationJournal of Medical Virology, 1980
- Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitisJournal of Medical Virology, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Techniques for Hemagglutination and Hemagglutination-Inhibition with Arthropod-Borne VirusesThe American Journal of Tropical Medicine and Hygiene, 1958
- Experimenteller und epidemiologischer Beitrag zur aktiven Immunisierung gegen die Fr hling-Sommer-ZeckenencephalitisArchiv für die gesamte Virusforschung, 1941